Cross-cultural validation of an international questionnaire, the General Measure of the Functional Assessment of Cancer Therapy scale (FACT-G), for Japanese

Cross-cultural validation of an international questionnaire, the General Measure of the Functional Assessment of Cancer Therapy scale (FACT-G), for Japanese
复制标题

DOI:
10.1023/a:1013851216181
复制
发表时间:
2001-01-01
影响因子:
3.5
通讯作者:
Kudoh, S
Kudoh, S
中科院分区:
医学2区
文献类型:
--
作者:
Fumimoto, H;Kobayashi, K;Kudoh, S

文献摘要

被引文献

相似文献

癌症治疗功能评估量表的一般测量(FACT-)是在英语文化(美国)中开发的。为了确定FACT-G是否可在日本使用,进行了跨文化验证。在评价性心理测量测试中,通过因子分析和多特质量表分析验证其结构。临床效度通过已知组间比较(包括分期、表现评分(PS)和患者所在地)进行评估,并通过PS进行纵向验证。对180例肺癌患者进行FACT-G(第3版)测试。分析表明,在日本的身体,功能,情感幸福感和与医生的关系的规模是建设性的有效性。日本患者认为家庭关系不同于与朋友和邻居的关系,这表明社会/家庭幸福感量表需要文化适应。两个项目有关应付疾病和接受疾病没有加载到各自的规模可预见的,被认为是跨文化的问题。然而,临床有效性证明了其敏感性。日文第4版已得到改进,以解决这一弱点,试图成为一种适用于不同文化的文书。
The General Measure of the Functional Assessment of Cancer Therapy scale (FACT-) was developed in an English-speaking culture (USA). To determine if FACT-G could be used in Japan, a cross-cultural validation was performed. The Japanese version was created through an iterative forward-backward translation sequence used througout the FACT multi-lingual translation project .In evaluation psychometric testing, its construct validated was investigated by factor analysis and multi-trait scaling analysis clinical validity was estimated by known-groups comparison using stage, performance score (PS) and patient location, and validated longitudinally by PS. The FACT-G (version 3) was given to 180 patients with lung cancer. Analyses showed that the scales of Physical, Functional, Emotional Well-Being, and Relationship with Doctors were constructively valid in Japan. Japanese patients felt that familial relationships were different than those with friends and neighbors, indicating that the Social/Family Well-Being scale needed cultural adaptation. Two items concerning coping with illness and acceptance of illness did not load predictably onto their respective scales and were considered to be cross-culturally problematic. However, clinical validity demonstrated its sensitivity. Japanese version 4 has been improved to address the weakness in an attempt to become an instrument that is applicable across cultures.